The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs

Christopher Larson(Johns Hopkins University), Stephen B. Howell(University of California, San Diego)

Molecular Pharmacology

November 8, 2008

10.1124/mol.108.052381

Cited by 181

Related Papers

Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs

|Molecular Pharmacology|2010|340

Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4

|PLoS ONE|2013|128

Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo

|Molecular Pharmacology|2010|67

The copper transporter 1 (CTR1) is required to maintain the stability of copper transporter 2 (CTR2)

|Metallomics|2015|38

The Role of the Methionines and Histidines in the Transmembrane Domain of Mammalian Copper Transporter 1 in the Cellular Accumulation of Cisplatin

|Molecular Pharmacology|2010|37